Microwave Technology Kills Biological Bacteria
RELATED SYMBOLS: (TCGI)
LAKEWOOD, N.J., Oct 11, 2001 (BUSINESS WIRE) -- The Classica Group, Inc.
(NASDAQ: TCGI) today announced that its Classica Microwave Technologies, Inc.
("CMT") subsidiary's pasteurization and sterilization systems can and will kill
biological bacterial threats, including anthrax, in products utilizing its
systems.
"Our technology is absolutely capable of killing anthrax or any other bacterial
contaminant without the use of irradiation," stated Scott Halperin, The Classica
Group's Chairman and CEO. "We are excited about utilizing our technology in the
fight against terrorism", he added.
"Our Chief Engineer, Guiseppe Ruozi, and his staff in Italy are working around
the clock to complete the design of an inexpensive system specifically to
process packages and mail upon receipt and prior to opening or distribution,"
Halperin continued, "we believe this could prevent a biological disaster similar
to the one that recently occurred in Florida."
The Classica Group's microwave technology segment utilizes microwave-based
technology to provide producers with the ability to deliver food, which
satisfies today's consumers' demands for bacterial integrity, convenience in
preparation, and quality. CMT's technology kills Salmonella, E-coli, Listeria,
and other bacteria, including anthrax. The producers will realize significant
production and packaging cost savings, which could be passed on to the consumer.
The Classica Group, Inc.'s Cucina Classica Italiana subsidiary imports and
produces under license Italian specialty cheeses and other premium specialty
foods, including the world-renowned brands from Egidio Galbani S.p.A.
Except for historical information contained herein, the matters discussed in
this news release are forward looking statements that involve risk and
uncertainties. The forward-looking statements in this release are made pursuant
to the safe harbor provisions of the Private Securities Litigation Reform Act of
1995. Actual results may differ materially due to a variety of factors,
including without limitation the presence of competitors with broader product
lines and greater financial resources; intellectual property rights and
litigation, needs of liquidity; and the other risks detailed from time to time
in the company's reports filed with the Securities and Exchange Commission.
CONTACT: The Classica Group, Inc., Lakewood
Scott Halperin, 1-(800)524-2713
URL: businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2001 Business Wire. All rights reserved.
-0-
KEYWORD: NEW JERSEY
INDUSTRY KEYWORD: BIOTECHNOLOGY
FOODS/BEVERAGES
MEDICAL
CONSUMER/HOUSEHOLD
SOURCE:
The
Classica
Group,
Inc.
(Public Company & Wall Street & Business & International) |
